MORF-057

DB23674InvestigationalSmall molecule

MORF-057 is a small molecule drug. MORF-057 is under investigation in clinical trial NCT06226883 (A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease).

Mechanism: Pharmacologically active on Integrin alpha-4 and Integrin beta-7
Curator reviewed
Code names: LY4268989 · MORF-057

Resolves to

Targets

P13612ITGA4P26010ITGB7

What you can answer from here — as of July 17, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with MORF-057, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account